Long-term lithium treatment increases cPLA2 and iPLA2 activity in cultured cortical and hippocampal neurons

Molecules

Volumn 20, Issue 11, 2015, Pages 19878-19885

  De Paula, Vanessa De Jesus ^a   Kerr, Daniel Shikanai ^a   De Carvalho, Marília Palma Fabiano ^a   Schaeffer, Evelin Lisete ^a   Talib, Leda Leme ^a   Gattaz, Wagner Farid ^a   Forlenza, Orestes Vicente ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CPLA2 activity; IPLA2 activity; Lithium; Neuronal cell culture

Indexed keywords

LITHIUM; PHOSPHOLIPASE A2;

ANIMAL; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; FEMALE; HIPPOCAMPUS; METABOLISM; NERVE CELL; PREGNANCY; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; LITHIUM; NEURONS; PHOSPHOLIPASES A2; PREGNANCY; PYRAMIDAL CELLS; RATS;

EID: 84949964928     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201119663     Document Type: Article

References (43)

1. Young, A.H. More good news about the magic ion: Lithium may prevent dementia. Br. J. Psychiatry 2011, 198, 336-337.
2. Chiu, C.T.; Chuang, D.M. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol. Ther. 2010, 128, 281-304.
3. Shaltiel, G.; Dalton, E.C.; Belmaker, R.H.; Harwood, A.J.; Agam, G. Specificity of mood stabilizer action on neuronal growth cones. Bipolar Disord. 2007, 9, 281-289.
4. Walz, J.C.; Frey, B.N.; Andreazza, A.C.; Ceresér, K.M.; Cacilhas, A.A.; Valvassori, S.S.; Quevedo, J.; Kapczinski, F. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J. Psychiatr. Res. 2008, 42, 416-421.
5. Yasuda, S.; Liang, M.H.; Marinova, Z.; Yahyavi, A.; Chuang, D.M. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 2009, 14, 51-59.
6. Guo, S.; Arai, K.; Stins, M.F.; Chuang, D.M.; Lo, E.H. Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke 2009, 40, 652-655.
7. Nonaka, S.; Hough, C.J.; Chuang, D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc. Natl. Acad. Sci. USA 1998, 95, 2642-2647.
8. Sarkar, S.; Floto, R.A.; Berger, Z.; Imarisio, S.; Cordenier, A.; Pasco, M.; Cook, L.J.; Rubinsztein, D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 2005, 170, 1101-1111.
9. Phiel, C.J.; Wilson, C.A.; Lee, V.M.Y.; Klein, P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423, 435-439.
10. Lovestone, S.; Davis, D.R.; Webster, M.T.; Kaech, S.; Brion, J.P.; Matus, A.; Anderton, B.H. Lithium reduces tau phosphorylation: Effects in living cells and in neurons at therapeutic concentrations. Biol. Psychiatry 1999, 45, 995-1003.
11. 2 activity. Neurochem. Res. 1998, 23, 887-892.
12. Chang, M.C.; Grange, E.; Rabin, O.; Bell, J.M.; Allen, D.D.; Rapoport, S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 1996, 220, 171-174.
13. Schaeffer, E.L.; Cerulli, F.G.; Souza, H.O.X.; Catanozi, S.; Gattaz, W.F. Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus. J. Neural Transm. 2014, 121, 695-706.
14. 2 in adult rats impairs the survival of newbornmature neurons in the hippocampus. J. Neural Transm. 2015, 122, 619-628.
15. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 2000, 275, 32783-32792.
16. 2 regulation of arachidonic acid mobilization. FEBS Lett. 2002, 531, 2-6.
17. 2 in the central nervous system: Implications for neurodegenerative diseases. J. Lipid Res. 2004, 45, 205-213.
18. 2: Aperspective on the history. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71, 161-169.
19. 2) enzymes in membrane trafficking: Mediators of membrane shape and function. Traffic 2003, 4, 214-221.
20. Rapoport, S.I. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 2001, 16, 243-261, Discussion 279-284.
21. Quiroz, J.A.; Machado-Vieira, R.; Zarate, C.A.; Manji, H.K. Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects. Neuropsychobiology 2010, 62, 50-60.
22. 2 activity in Alzheimer brains. Biol. Psychiatry 1995, 37, 13-17.
23. Nunes, P.V.; Forlenza, O.V.; Gattaz, W.F. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br. J. Psychiatry 2007, 190, 359-360.
24. 2 in platelets. Prostaglandins Leukot. Essent. Fatty Acids 2012, 86, 149-153.
25. 2 activity in rat embryonic brain and in primary cultures of cortical neurons. J. Neural Transm. 2002, 109, 623-631.
26. 6 in human fetal development: Implications for infantile neuroaxonal dystrophy. Brain Res. Bull. 2010, 83, 374-379.
27. 2 and release of arachidonic acid and other lipid mediators at the synapse: The role of platelet-activating factor. J. Lipid Mediat. 1993, 6, 421-427.
28. 2. FEBS Lett. 1995, 377, 358-362.
29. 2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 2005, 77, 235-248.
30. Clements, M.P.; Bliss, T.V.; Lynch, M.A. Increase in arachidonic acid concentration in a postsynaptic membrane fraction following the induction of long-term potentiation in the dentate gyrus. Neuroscience 1991, 45, 379-389.
31. Drapeau, C.; Pellerin, L.; Wolfe, L.S.; Avoli, M. Long-term changes of synaptic transmission induced by arachidonic acid in the CA1 subfield of the rat hippocampus. Neurosci. Lett. 1990, 115, 286-292.
32. Williams, J.H.; Errington, M.L.; Lynch, M.A.; Bliss, T.V. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 1989, 341, 739-742.
33. 2 in exocytosis of amylase from parotid acinar cells. J. Biochem. 1997, 121, 1018-1024.
34. 2 inhibitor in rat hippocampal slices. Br. J. Pharmacol. 2001, 132, 1417-1422.
35. 2 activity in primary cultures of rat cortical neurons. J. Neural Transm. 2005, 112, 1297-1308.
36. Camins, A.; Verdaguer, E.; Junyent, F.; Yeste-Velasco, M.; Pelegrí, C.; Vilaplana, J.; Pallás, M. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci. Ther. 2009, 15, 333-344.
37. Forlenza, O.V.; de Paula, V.J.; MacHado-Vieira, R.; Diniz, B.S.; Gattaz, W.F. Does lithium prevent Alzheimer's disease? Drugs Aging 2012, 29, 335-342.
38. Hernandez, F.; Lucas, J.J.; Avila, J. GSK3 and tau: Two convergence points in Alzheimer's disease. J. Alzheimers Dis. 2013, 33, S141-S144.
39. Forlenza, O.V.; De-Paula, V.J.R.; Diniz, B.S.O. Neuroprotective effects of lithium: Implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem. Neurosci. 2014, 5, 443-450.
40. 2 activity in the brain and in platelets of patients with Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246, 129-131.
41. 2 activity. J. Neurochem. 1998, 70, 786-793.
42. 2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients. Eur. Arch. Psychiatry Clin. Neurosci. 2015.
43. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.